Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 1,628,000 | 1,816,000 | 1,730,000 | 1,574,000 | 1,584,000 |
| Cost of Goods | 1,151,000 | 1,259,000 | 1,193,000 | 1,088,000 | 1,119,000 |
| Gross Profit | 477,000 | 557,000 | 537,000 | 486,000 | 465,000 |
| Operating Expenses | 195,000 | 191,000 | 173,000 | 211,000 | 181,000 |
| Operating Income | 282,000 | 366,000 | 364,000 | 275,000 | 284,000 |
| Interest Expense | 47,000 | 48,000 | 52,000 | 54,000 | 55,000 |
| Other Income | 34,000 | 5,000 | 69,000 | 43,000 | 21,000 |
| Pre-tax Income | 269,000 | 323,000 | 381,000 | 264,000 | 250,000 |
| Income Tax | -6,000 | 41,000 | 84,000 | 36,000 | 43,000 |
| Net Income Continuous | 275,000 | 282,000 | 297,000 | 228,000 | 207,000 |
| Minority Interests | N/A | 1,000 | N/A | N/A | N/A |
| Net Income | $275,000 | $281,000 | $297,000 | $228,000 | $207,000 |
| EPS Basic Total Ops | 1.56 | 1.58 | 1.63 | 1.23 | 1.12 |
| EPS Basic Continuous Ops | 1.56 | 1.59 | 1.63 | 1.23 | 1.12 |
| EPS Diluted Total Ops | 1.51 | 1.53 | 1.58 | 1.20 | 1.08 |
| EPS Diluted Continuous Ops | 1.51 | 1.53 | 1.58 | 1.19 | 1.08 |
| EBITDA(a) | $355,000 | $442,000 | $437,000 | $347,000 | $349,000 |